NanoString Blog
Oncology
Statistically Significant Results without the Headache. Q&A with Sarah Church, Ph.D., Senior Scientist at NanoString.
Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString and one of the warmest people…
Immunology Infectious Disease
COVID-19 Pathogenesis Steps Out of the Shadows
“Analysis of pulmonary vessels showed that widespread thrombosis with microangiopathy ─ a severe condition wherein small blood clots are formed within the tiniest of blood vessels ─ was 9x more…
Spotlight on a CRO: Interview with the Team of Scientists behind NeoGenomics Pharma Services
NeoGenomics is a cancer diagnostics and pharma services company serving pharmaceutical companies and academic centers. They specialize in diagnostic, prognostic and predictive testing using the most innovative technologies. The company…
Oncology
Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.
Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a…
Immunology Oncology
Why is Spatial Transcriptomics Critical to Studying Sarcomas? Q&A with Dr. Troy McEachron, Ph.D
“Whereas the EWS specimens tended to have very simple genomes, the osteosarcoma specimens looked like a hand grenade had gone off in the genome. These were the most fragmented and…
Grants Transplants
Solid Organ Transplantation and the Immunology of Rejection. Q&A with GeoMx® Digital Spatial Profiler Grant Winner Dr. Fadi Issa
“Cancer immunotherapy and transplantation are basically the same field; one’s just the flip side of the other”. Dr. Fadi Issa Have you ever been to Oxford? Situated in the gorgeous…
Grants Transplants
Searching for New Biomarkers to Prevent Organ Transplant Rejection. Q&A with HOT Panel Grant Winner Dr. Evan Farkash
Bob’s first question to me was: “How much do you want to learn about kidney pathology?” My response was that I wanted to learn as much as I could, and…
Spotlight on a CRO. Q&A with Dr. Edward J. Weinstein, Ph.D., CEO and co-founder of Canopy BioSciences.
There is a lot to love in the beautiful city of St. Louis: from the quiet neighborhoods permeated with old world charm to the picturesque streets reminiscent of Paris “petites…
Oncology
Top Ten Challenges in Cancer Immunology & Immunotherapy
Cancer immunotherapy (CIT) research and investments have progressed in the past few years thanks to its successful application across a…
Grants
Research Grant Preparation: Tips and Resources
Grant writing is a critical, albeit time-consuming, part of every scientist’s job. It is always Grant Writing Time! How often did you end up rushing at the last moment to…
Grants Transplants
Q&A with Paola Cassoni, M.D., Ph.D. on Understanding the Pathway to Organ Rejection.
Turin is a lovely Italian city situated between the western and northern borders of Italy by the Alps, looking east at the Monferrato Hills. The Mole Antonelliana, the proud city…
Digital Spatial Profiling
Q&A with Dr. Aubrey Thompson, Ph.D.: The GeoMx® Digital Spatial Profiler is Turning the Tables on Breast Cancer
E. Aubrey Thompson, Ph.D is a Professor in the Department of Cancer Biology at the Mayo Clinic in Jacksonville, FL. His research focuses on breast cancer and using genomic and…